Predictability of the Response to the Ergonovine Test: Value in the Diagnosis of Coronary Spasm

Joseph L. Gerry, Stephen C Achuff, Lewis Becker, Malcolm S. Pond, H. Leon Greene

Research output: Contribution to journalArticle

Abstract

Thirty-five patients with atypical chest pain were given ergonovine maleate as a provocative test for coronary spasm. None of the patients had significant coronary atherosclerosis. The patients were divided into two groups based on clinical information available before ergonovine testing. Group 1 patients (n=13) had objective evidence of cardiac disease manifested by episodes of syncope, ventricular tachyarrhythmias, myocardial infarction, or transient ST segment shifts with chest pain. Group 2 patients had chest pain but no objective evidence of cardiac disease. The ergonovine test was positive in 11 of 13 patients in group 1. None of the 22 group 2 patients had a positive response to ergonovine. These data suggest that ergonovine testing does not allow for any more precise recognition of patients with atypical chest pain who have coronary artery spasm than do clinical data alone.

Original languageEnglish (US)
Pages (from-to)2858-2861
Number of pages4
JournalJournal of the American Medical Association
Volume242
Issue number26
DOIs
StatePublished - Dec 28 1979

Fingerprint

Ergonovine
Spasm
Chest Pain
Heart Diseases
Syncope
Tachycardia
Coronary Artery Disease
Coronary Vessels
Myocardial Infarction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Predictability of the Response to the Ergonovine Test : Value in the Diagnosis of Coronary Spasm. / Gerry, Joseph L.; Achuff, Stephen C; Becker, Lewis; Pond, Malcolm S.; Greene, H. Leon.

In: Journal of the American Medical Association, Vol. 242, No. 26, 28.12.1979, p. 2858-2861.

Research output: Contribution to journalArticle

@article{9b6eacfcac4d481da1771c2fafba7011,
title = "Predictability of the Response to the Ergonovine Test: Value in the Diagnosis of Coronary Spasm",
abstract = "Thirty-five patients with atypical chest pain were given ergonovine maleate as a provocative test for coronary spasm. None of the patients had significant coronary atherosclerosis. The patients were divided into two groups based on clinical information available before ergonovine testing. Group 1 patients (n=13) had objective evidence of cardiac disease manifested by episodes of syncope, ventricular tachyarrhythmias, myocardial infarction, or transient ST segment shifts with chest pain. Group 2 patients had chest pain but no objective evidence of cardiac disease. The ergonovine test was positive in 11 of 13 patients in group 1. None of the 22 group 2 patients had a positive response to ergonovine. These data suggest that ergonovine testing does not allow for any more precise recognition of patients with atypical chest pain who have coronary artery spasm than do clinical data alone.",
author = "Gerry, {Joseph L.} and Achuff, {Stephen C} and Lewis Becker and Pond, {Malcolm S.} and Greene, {H. Leon}",
year = "1979",
month = "12",
day = "28",
doi = "10.1001/jama.1979.03300260028022",
language = "English (US)",
volume = "242",
pages = "2858--2861",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "26",

}

TY - JOUR

T1 - Predictability of the Response to the Ergonovine Test

T2 - Value in the Diagnosis of Coronary Spasm

AU - Gerry, Joseph L.

AU - Achuff, Stephen C

AU - Becker, Lewis

AU - Pond, Malcolm S.

AU - Greene, H. Leon

PY - 1979/12/28

Y1 - 1979/12/28

N2 - Thirty-five patients with atypical chest pain were given ergonovine maleate as a provocative test for coronary spasm. None of the patients had significant coronary atherosclerosis. The patients were divided into two groups based on clinical information available before ergonovine testing. Group 1 patients (n=13) had objective evidence of cardiac disease manifested by episodes of syncope, ventricular tachyarrhythmias, myocardial infarction, or transient ST segment shifts with chest pain. Group 2 patients had chest pain but no objective evidence of cardiac disease. The ergonovine test was positive in 11 of 13 patients in group 1. None of the 22 group 2 patients had a positive response to ergonovine. These data suggest that ergonovine testing does not allow for any more precise recognition of patients with atypical chest pain who have coronary artery spasm than do clinical data alone.

AB - Thirty-five patients with atypical chest pain were given ergonovine maleate as a provocative test for coronary spasm. None of the patients had significant coronary atherosclerosis. The patients were divided into two groups based on clinical information available before ergonovine testing. Group 1 patients (n=13) had objective evidence of cardiac disease manifested by episodes of syncope, ventricular tachyarrhythmias, myocardial infarction, or transient ST segment shifts with chest pain. Group 2 patients had chest pain but no objective evidence of cardiac disease. The ergonovine test was positive in 11 of 13 patients in group 1. None of the 22 group 2 patients had a positive response to ergonovine. These data suggest that ergonovine testing does not allow for any more precise recognition of patients with atypical chest pain who have coronary artery spasm than do clinical data alone.

UR - http://www.scopus.com/inward/record.url?scp=84943670227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943670227&partnerID=8YFLogxK

U2 - 10.1001/jama.1979.03300260028022

DO - 10.1001/jama.1979.03300260028022

M3 - Article

C2 - 513254

AN - SCOPUS:84943670227

VL - 242

SP - 2858

EP - 2861

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 26

ER -